INTERNATIONAL PATENT: SOLVO BIOTHERAPEUTICS (SHANGHAI) LIMITED, 烁微生物医药（上海）有限公司 FILES APPLICATION FOR "MONOCLONAL ANTIBODY SPECIFICALLY BINDING TO HEGFR AND BISPECIFIC ANTIBODY"

GENEVA, July 28 -- SOLVO BIOTHERAPEUTICS (SHANGHAI) LIMITED (Unit 602, 6th Floor, Building 1, No.795 Kangwei RoadPudong New Area, Shanghai 201315), 烁微生物医药（上海）有限公司 (中国上海市浦东新区康威路795号1号楼6楼602单元) filed a patent application (PCT/CN2024/131632) for "MONOCLONAL ANTIBODY SPECIFICALLY BINDING TO HEGFR AND BISPECIFIC ANTIBODY" on Nov 12, 2024. With publication no. WO/2025/152586, the details related to the patent application was published on Jul 24, 2025.

Notably, the patent application was submitted under the International Paten...